Picture of Bio Path Holdings logo

BPTH Bio Path Holdings Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Bio Path Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-8.6-10.9-10.4-13.9-16.1
Depreciation
Amortisation
Non-Cash Items0.780.6560.9060.9411.1
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.676-0.806-0.459-2.263.36
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Cash from Operating Activities-8.36-11-9.92-15.1-11.5
Capital Expenditures0-0.07-0.021
Purchase of Fixed Assets
Cash from Investing Activities0-0.07-0.021
Net Issuance / Retirement of Stock
Cash from Financing Activities27.84.29201.732.2
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash19.4-6.6710-13.4-9.33